Key European InsurTech investment stats in H1 2026:
- European InsurTech investments surged 3x YoY
- Trend analysis shows a projected 3.8x jump in funding for 2026 driven by a growth in deals over $100m
- Alan, a digital health insurance platform serving employees, freelancers and retirees across France, Spain, Belgium and Canada, raised $544.6m making it the top European InsurTech deal of the first half of the year
European InsurTech investments surged 3x YoY
European InsurTech companies raised $985.9m across 27 deals in H1 2026, a 3x increase in funding compared to the $327.5m recorded in H1 2025, even as deal count rose only modestly from 25 transactions over the same period.
That tripling of capital on a near-unchanged volume of deals is a remarkable result, and one that places H1 2026 in exceptional context.
The average deal size surged 2.9x to $36.5m from $13.1m in H1 2025, and well above the $12.1m average recorded across 2025.
Strikingly, H1 2026’s funding of $985.9m already exceeds the annual totals for both 2025 and 2024, underscoring just how significant a departure this half represents from recent norms.
Set against 2025’s total of $519.6m across 43 deals, H1 2026 accounts for 2.9x of last year’s funding from 63% of its deal volume.
Trend analysis shows a projected 3.8x jump in funding for 2026 driven by a growth in deals over $100m
Should H1 2026’s pace continue, 2026 would close with 54 deals and $1.98bn in total funding, representing a 26% increase in deal volume and a 3.8x rise in capital raised compared to 2025.
The funding breakdown in H1 2026 is defined almost entirely by two transactions.
Deals of $100m or more contributed $660.2m in H1 2026, a 3.8x increase on the $175m recorded in H1 2025, and their share of total half-year funding rose from 53% to 67%.
Both of those large transactions were raised by Alan, the French digital health insurer, whose fundraising activity alone has reshaped the complexion of European InsurTech investment in the period.
Smaller deals raised $325.7m in H1 2026, a 2.1x increase on the $152.5m recorded in H1 2025, with their share of total funding falling from 47% to 33%.
Across 2025, larger transactions contributed $175m, or 34% of annual funding, with sub-$100m deals accounting for the remaining $344.6m, or 66%.
The contrast with H1 2026 is sharp.
Removing Alan’s two rounds and the underlying market looks considerably more subdued, a reminder that the headline figure, while genuinely striking, rests on a very narrow foundation.
Alan, a digital health insurance platform serving employees, freelancers and retirees across France, Spain, Belgium and Canada, raised $544.6m making it the top European InsurTech deal of the first half of the year
The round was led by Prosus.
Alan now serves more than 1.1 million members and 37,000 businesses, and reported annual recurring revenue of $907.7m in Q1 2026, with a credible path to $1.1bn by year-end.
Much of the company’s durability can be attributed to its distribution strategy, which is built primarily through employer channels and group benefits rather than costly direct-to-consumer acquisition, a model that delivers structurally higher retention and more predictable loss ratios than many of its digital-first peers managed.
Its AI-native platform is described as central to claims automation, care navigation and prevention, and at this scale the operational numbers suggest the model is holding together.
Alan expanded into Spain, Belgium and Canada only after validating its core economics in France, a discipline that set it apart from the wave of InsurTechs that scaled across borders before proving local unit economics and were undone by the regulatory complexity that makes European insurance particularly unforgiving.
Having survived where most challengers did not, Alan now sets a new benchmark for what institutional investors consider an investable InsurTech: disciplined distribution, demonstrable unit economics and a credible path to profitability in at least one market before expansion.
Keep up with all the latest InsurTech news here
Copyright © 2026 InsurTech Analyst
